Absci (ABSI) Capital Expenditures (2020 - 2026)
Absci's Capital Expenditures was $1,000 in Q2 2026, down 99.6% from $223,000 a year earlier and down 96.7% from the prior quarter.
Absci (ABSI) Capital Expenditures (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Absci's Capital Expenditures was $890,000 through Jun 30, 2026, up 179.0% year-over-year; for FY2025, it came in at $1.11 million, up 174.0% from FY2024.
- Capital Expenditures shows a five-year compound annual growth rate of -12.7% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $404,000 in FY2024 (-53.0%), $860,000 in FY2023 (-94.7%), $16.18 million in FY2022 (-57.5%) and $38.05 million in FY2021.
- Quarterly Capital Expenditures has moved between -$103,000 (Q4 2025) and $8.32 million (Q4 2021) over five years.
- Compared with a year earlier, Capital Expenditures was higher in two of the last five quarters, with an average decline of 32.3%.
- The best year-over-year quarter for Capital Expenditures over five years was Q4 2021 (growth of 803.9%); the worst was Q2 2026 (a decline of 99.6%).
- Per Business Quant data, ABSI's Capital Expenditures in the three quarters before Q2 2026 was $30,000 (Q1 2026), -$103,000 (Q4 2025) and $962,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Absci | 1.85 Bn | 1.22 Bn | - | 1,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | -103,000.00 |
| Sep 30, 2025 | 962,000.00 |
| Jun 30, 2025 | 223,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 23,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Jun 30, 2024 | 333,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | 307,000.00 |
| Jun 30, 2023 | 256,000.00 |
| Mar 31, 2023 | 280,000.00 |
| Dec 31, 2022 | 560,000.00 |
| Sep 30, 2022 | 4.87 Mn |
| Jun 30, 2022 | 3.89 Mn |
| Mar 31, 2022 | 6.86 Mn |
| Dec 31, 2021 | 8.32 Mn |
| Sep 30, 2021 | 5.62 Mn |
| Jun 30, 2021 | 17.75 Mn |
Absci Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ABSI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ABSI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ABSI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();